Ganga Pharmaceuticals Ltd
Ganga Pharmaceuticals Board Meeting to Approve FY26 Audited Financial Results
BOARD
● No Immediate Change
LOW RISK
📅 Filed on BSE: 14 May 2026, 03:20 PM IST · BSE ID: 12218b78-12a5-4ae7-b5a4-fbc509106349
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's board will meet on May 21, 2026, to approve its financial results for the year ending March 2026.
🤖 AI Summary
- Board of Directors meeting scheduled for Ganga Pharmaceuticals Ltd on May 21, 2026.
- Primary agenda includes considering and approving Audited Financial Results for FY26.
- Results cover the half year and full financial year ended March 31, 2026.
- Trading window for company securities is closed from April 01, 2026.
- Trading window will reopen 48 hours after the Audited Financial Results are declared.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time based on this intimation.
👤
Who Is Affected
All shareholders are affected as the upcoming financial results will provide updated information on the company's performance for the half-year and full financial year ended March 31, 2026.
🔍
Management Signal
Management is adhering to regulatory requirements by intimating the board meeting for financial results approval, indicating a focus on compliance and timely disclosure.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Ganga Pharmaceuticals' Board Meeting on May 21, 2026 for result approval.
Announcement of Audited Financial Results for FY26 following the meeting.
Reopening of the trading window 48 hours after financial results declaration.
LOW RISK
This filing is a routine intimation of an upcoming board meeting, posing no immediate new risks.
💡 Investor Takeaway
Ganga Pharmaceuticals Ltd's Board of Directors will convene on May 21, 2026, to review and approve the Audited Financial Results for the half year and financial year ended March 31, 2026. The trading window is currently closed for designated persons and will re-open after the results declaration.
📅 Company Track Record
No previous filings found for Ganga Pharmaceuticals Ltd indicate a limited public track record available. This upcoming release of Audited Financial Results for FY26 will be a key disclosure for the company.
Based on publicly available historical data. For context only.